Study on the Efficacy of Laparoscopic-Assisted Thyroglossal Duct Cyst Resection Via Submental Approach
2 other identifiers
interventional
60
0 countries
N/A
Brief Summary
Thyroglossal duct cysts are congenital diseases of the neck. Once detected, surgical treatment is the first choice. The traditional Sistrunk surgery has definite efficacy but leaves scars on the neck. With the popularization of the concept of minimally invasive surgery, the non-inflated submandibular approach endoscopic technique provides a new idea for achieving a scar-free resection of the neck. This project intends to conduct a randomized controlled study to scientifically evaluate the clinical efficacy and safety of submandibular approach endoscopic-assisted resection of thyroglossal duct cysts. The study plans to include 60 newly diagnosed patients, randomly divided into the experimental group (submandibular approach endoscopic resection of thyroglossal duct cysts) and the control group (traditional open surgery). Systematically compare the perioperative indicators (operation time, intraoperative blood loss, average hospital stay), postoperative pain (VAS score), complications (infection, recurrence, injury of the sublingual nerve), and incision satisfaction (Vancouver Scar Scale) between the two groups. This project is expected to establish a standardized surgical procedure, verify the superiority of this technique in achieving a scar-free neck while ensuring complete resection of the lesion, provide evidence-based medical evidence for the promotion of scar-free surgery in the neck, and have both clinical innovation and social benefits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2026
CompletedFirst Posted
Study publicly available on registry
August 21, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
Study Completion
Last participant's last visit for all outcomes
June 30, 2028
August 21, 2026
August 1, 2026
1.8 years
July 8, 2026
August 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Perioperative Clinical Indicators
Includes operation time (minutes), intraoperative blood loss (mL), and postoperative length of hospital stay (days).
Perioperative
Vancouver Scar Scale (VSS) Score
VSS evaluates scars across 4 subscales: pigmentation, thickness, vascularity, and pliability. Subscale scores are summed to generate a total score (range 0-15, with higher scores reflecting more severe scarring).
up to 6 mouth
Pain Intensity assessed by Visual Analogue Scale (VAS)
A 10-cm horizontal line anchored by 0 (no pain) and 10 (worst imaginable pain). Participants mark a point corresponding to their current pain level. Higher scores indicate worse pain.
up to 72 hours
Secondary Outcomes (1)
Total Postoperative Negative-Pressure Wound Drainage Volume
up to Day 2
Study Arms (2)
Submental endoscopic-assisted Sistrunk operation
EXPERIMENTALAfter general anesthesia, the patient lies in a supine position with the neck slightly extended backward. A concealed incision of approximately 2-3 centimeters in length is made along the natural skin fold at about 1 centimeter below the chin (the submental area). Through this incision, a blunt dissection is performed at the subcutaneous thin muscle layer level to form a subcutaneous tunnel that extends directly to the thyroid cartilage region. The surgery is assisted by an endoscope with a suspension and traction system and without the need for inflation. Under high-definition endoscopic visualization, the thyroglossal duct cyst, the middle segment of the hyoid bone, and the path of the thyroglossal duct are carefully separated and completely resected. A closed drainage tube is placed. The submental incision is sutured using absorbable sutures within the dermis.
Conventional open Sistrunk operation via cervical incision
ACTIVE COMPARATORAfter general anesthesia, the patient is placed in the supine position with the neck extended. A horizontal skin incision is made along the midline of the neck directly over the thyroglossal duct cyst. The skin and subcutaneous tissues are divided. The strap muscles (sternohyoid and thyrohyoid) are separated in the midline to expose the cyst and the body of the hyoid bone. The thyroglossal duct cyst is dissected en bloc together with the central portion of the hyoid bone, preserving the surrounding vital structures. The surgical wound is thoroughly irrigated with normal saline. The incision is closed in layers with absorbable sutures, and a sterile dressing is applied.
Interventions
After general anesthesia, the patient is placed in the supine position with the neck slightly extended. A concealed transverse skin incision of approximately 2-3 cm is made about 1 cm below the chin (submental area), following the natural skin creases. Through this incision, blunt dissection is performed in the subplatysmal plane to create a subcutaneous tunnel reaching the hyoid bone region. The operation is assisted by an endoscope with a suspended retractor system without gas insufflation, thus avoiding the risk of gas embolism. Under high-definition endoscopic visualization, the thyroglossal duct cyst, the middle segment of the hyoid bone, and the track of the thyroglossal duct are meticulously dissected and completely resected en bloc. Hemostasis is achieved carefully to preserve the recurrent laryngeal and hypoglossal nerves. The wound is thoroughly irrigated with normal saline. A closed suction drain is placed if necessary. The submental incision is closed with intradermal absor
Make an incision in the middle of the skin on the neck, cut through the skin and subcutaneous tissue, expose the tumor and the hyoid bone, and completely remove the thyroglossal
Eligibility Criteria
You may qualify if:
- The cyst is in the non-acute infection stage;
- The cyst has not ruptured to form a skin sinus tract or fistula;
- Preoperative B-ultrasound and CT indicated that it was a thyroglossal duct cyst;
- There are no severe underlying heart or lung diseases or coagulation dysfunction;
- The patient and their family voluntarily chose to undergo laparoscopic resection of the thyroglossal duct cyst; ⑥ The patient and their family voluntarily signed the informed consent form.
You may not qualify if:
- The cyst is in the acute infection stage;
- The cyst ruptures, forming a skin sinus tract or fistula; ③ Has severe underlying heart and lung diseases and coagulation dysfunction; ④ Those with cyst diameters greater than 4 cm; ⑤ Those currently participating in other research studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Rohof D, Honings J, Theunisse HJ, Schutte HW, van den Hoogen FJ, van den Broek GB, Takes RP, Wijnen MH, Marres HA. Recurrences after thyroglossal duct cyst surgery: Results in 207 consecutive cases and review of the literature. Head Neck. 2015 Dec;37(12):1699-704. doi: 10.1002/hed.23817. Epub 2014 Sep 25.
PMID: 24985922RESULTEllis PD, van Nostrand AW. The applied anatomy of thyroglossal tract remnants. Laryngoscope. 1977 May;87(5 Pt 1):765-70. doi: 10.1002/lary.5540870512.
PMID: 850454RESULTSistrunk WE. THE SURGICAL TREATMENT OF CYSTS OF THE THYROGLOSSAL TRACT. Ann Surg. 1920 Feb;71(2):121-122.2. doi: 10.1097/00000658-192002000-00002. No abstract available.
PMID: 17864229RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
fei L Yue, PG
People's Hospital of Anshun City of Guizhou Province
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Given the inconsistency of the treatment methods in this trial, this project adopts a single-blind method (blindness for the patients). However, we will strictly adhere to the principle of separating the blind method from the research. Researchers who are not involved in the experiment will prepare the random table and assign the patients who meet the diagnostic criteria with the corresponding surgical treatment plan based on the order of their visits. During the experiment, the researchers conducting the study do not participate in the statistical analysis of the experimental data. The efficacy evaluation indicators will be evaluated by a third party, and the data statisticians will be blinded. The bottom of the blinding process is known only to the research designer and is kept confidential by a dedicated person.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate chief physician
Study Record Dates
First Submitted
July 8, 2026
First Posted
August 21, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
August 21, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share